SCHEMBL25512864

SCHEMBL25512864

CCC(C)(O)c1cccc(C(=O)NCC(N)=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.49
POLB P06746 1/20 0.49
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
TP53BP1 Q12888 2/20 0.44
MRGPRX4 Q96LA9 1/20 0.43
GPR139 Q6DWJ6 1/20 0.43
TAS1R3 Q7RTX0 2/20 0.42
TAS1R1 Q7RTX1 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CCR2 P41597 1/20 0.42
TP53 P04637 1/20 0.41
HPGDS O60760 1/20 0.41
GPR52 Q9Y2T5 1/20 0.41
DDR1 Q08345 2/20 0.41
SPHK2 Q9NRA0 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25512865 1.00 ALDH1A1 (0.49) ALDH1A1POLBCA12CA1CA2
SCHEMBL13501434 0.86 ACHE (0.53) ALDH1A1POLBTP53BP1MRGPRX4GPR139
SCHEMBL7641409 0.80 POLB (0.65) ALDH1A1POLBTP53BP1MRGPRX4GPR139
SCHEMBL24464737 0.77 ACHE (0.49) ALDH1A1POLBTP53BP1TAS1R3TAS1R1
SCHEMBL23715021 0.76 NPC1 (0.55) POLBCA12CA1CA2CA9
SCHEMBL23714965 0.75 MRGPRX4 (0.41) ALDH1A1POLBCA1CA2TP53BP1
SCHEMBL23714782 0.75 HDAC8 (0.59) POLBCA1CA2GPR139SMN1; SMN2
SCHEMBL8298056 0.73 KDM4E (0.53) ALDH1A1MRGPRX4SMN1; SMN2SPHK2GAA
SCHEMBL14725927 0.72 TP53BP1 (0.54) ALDH1A1TP53BP1MRGPRX4SMN1; SMN2HPGDS
SCHEMBL14725929 0.72 SPHK2 (0.47) ALDH1A1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149414-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149414-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB ALDH1A1 2571/4885POLB 165/4885CA12 4343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.